INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH - Nyxoah ( NASDAQ:NYXH )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ( "Nyxoah" or the "Company" ) NYXH. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYW - Flywire ( NASDAQ:FLYW )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Flywire Corporation ( "Flywire" or the "Company" ) FLYW. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endeavour Silver Corp. - EXK - Endeavour Silver ( NYSE:EXK )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Endeavour Silver Corp. ( "Endeavour" or the "Company" ) EXK. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Adverum Biotechnologies ( NASDAQ:ADVM )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. ( "Adverum" or the "Company" ) ADVM. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX - Aldeyra Therapeutics ( NASDAQ:ALDX )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( "Aldeyra" or the "Company" ) ALDX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Robinhood Markets, Inc. - HOOD - Robinhood Markets ( NASDAQ:HOOD )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Robinhood Markets, Inc. ( "Robinhood" or the "Company" ) HOOD. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY - Pony AI ( NASDAQ:PONY )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Pony AI Inc. ( "Pony" or the "Company" ) PONY. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - Sarepta Therapeutics ( NASDAQ:SRPT )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ( "Sarepta" or the "Company" ) SRPT. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Canopy Growth Corporation and Certain Officers - CGC - Canopy Gwth ( NASDAQ:CGC )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation ( "Canopy" or the "Company" ) CGC and certain officers.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX - RLX Technology ( NYSE:RLX )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. ( "RLX" or the "Company" ) RLX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
